WCCO EYE4 LOGO WCCO Radio wcco-eye-white01, ww color white

Medtronic Inc.

health generic, lab, testing, microscope, doctor

FDA Pledges Support For Med Tech Initiative

The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.

12/03/2012

(credit: John Moore/Getty Images)

U Of M Cautions Surgeon Over Disclosures

The University of Minnesota Medical School has sent a cautionary letter to one of its top spinal surgeons for violating conflict-of-interest disclosure requirements arising from his work for Medtronic Inc.

12/20/2011

(credit: Medtronic)

Medtronic To Pay $23.5M To Settle Kickback Claims

Medtronic Inc., the world’s largest maker of medical devices, has agreed to pay $23.5 million to settle allegations that it paid kickbacks to doctors to implant its pacemakers and defibrillators, the U.S. Justice Department said Monday.

12/12/2011

Medtronic, building, generic

Medtronic 2Q Profit Rises On Favorable Comparison

Medtronic Inc., the world’s largest medical device maker, reported higher-than-expected earnings Tuesday as overall sales edged up despite continuing pressure on the company’s best-selling heart and spine implants.

11/22/2011

Medtronic, building, generic

FDA Warns Of Complications With Medtronic Catheter

Federal health regulators say an experimental catheter from Medtronic Inc. that uses extreme heat to correct irregular heartbeats caused safety side effects in nearly one-fifth of patients treated, far exceeding the study’s safety goal.

10/25/2011

(credit: Medtronic)

Medtronic Picks GE’s Omar Ishrak As Next CEO

Medtronic Inc., the world’s largest medical device maker, has selected the head of GE Healthcare to become its chief executive as it tries to re-energize sales in the midst of an industrywide slump.

05/11/2011

Medtronic, building, generic

Medtronic Resolves FDA Warnings Over 2 Factories

Medtronic Inc., the world’s largest medical device company, said Wednesday it has resolved two warning letters from the Food and Drug Administration over lax oversight at two manufacturing plants, clearing the way for new product approvals.

03/09/2011